title: Control of flares and relief of urate burden with canakinumab and targeted urate-lowering therapy in tophaceous gouty arthritis.
authors.affiliation: Department of Rheumatology, Clinical Immunology, and Allergy, University Hospital of Heraklion, Stavrakia Voutes, 71110 Heraklion, Crete, Greece. afanouriakis@edu.med.uoc.gr.
authors.forename: Antonis
authors.initials: A
authors.lastname: Fanouriakis
authors.forename: Apostolos
authors.initials: A
authors.lastname: Karantanas
authors.forename: Eleni
authors.initials: E
authors.lastname: Fragouli
authors.forename: Argyro
authors.initials: A
authors.lastname: Repa
authors.forename: Prodromos
authors.initials: P
authors.lastname: Sidiropoulos
mesh_terms: D000328:Adult; D000493:Allopurinol / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D015210:Arthritis, Gouty / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006074:Gout Suppressants / Q000627:therapeutic use*; D006801:Humans; D033461:Hyperuricemia / Q000150:complications / Q000188:drug therapy*; D008297:Male; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D006074:Gout Suppressants; C541220:canakinumab; D000493:Allopurinol